Insider filing · MANE
Veradermics, Incorporated
MANE · Healthcare · 10 filings in 24 months
ticker →
John W Childs bought $5.0M of Veradermics (MANE)
Executed Feb 5, disclosed Feb 27, 22 days later, against a two-business-day limit.
Value, as filed
$5.0M
294,117 sh × $17.00
Executed
Feb 5
the trade date, as filed
Disclosed
Feb 27
22 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
JC
John W Childs
Director
profile →
John W Childs (Director) filed 5 Form 4 reports in the trailing twelve months (4 purchases, 1 sale, 2 filed past the two-business-day deadline), most often in BHVN. Across 2 priced purchase filings, the average 21-session return was +37.0% from execution and +27.3% from disclosure (delay-adjusted; derived). The largest single filing was $25.0M of BHVN (3,333,333 sh × $7.50, as filed), executed Nov 13 2025.
The name
MANEHealthcare · Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthe…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John W Childs in MANE
MANESALE
Veradermics, Incorporated
$10.7M100,000 sh across 3 lots
Exec Aug 12
Filed Aug 14 · 6:01 PM ET MANEPURCHASE Veradermics, Incorporated $5.0M
294,117 sh × $17.00
Exec Feb 5
Filed Feb 5 · 7:04 PM ET